Displaying items by tag: department of medicine

The complement system is part of the body’s immune system to fight pathogens and remove cell debris. Its role in two autoimmune diseases and a mental disorder is a surprise.
A new rapid sexually transmitted infection test developed through research done at UAB will help diagnose and treat patients in real time moving forward.
Dual antiplatelet therapy after percutaneous coronary intervention uses aspirin and one other drug, among several choices. But which drug is best to use?
UAB is part of several trials testing infusion of antibodies from people who have beaten COVID-19 to help those dealing with infection or at risk for infection. Donors are needed.
A study conducted by UAB investigators has outlined the importance of strict blood pressure control in the development of atrial fibrillation, which can lead to poor outcomes such as stroke, heart attacks and death.
UAB researchers have quickly developed and launched multiple research studies geared at treating or preventing COVID-19, following generous funding support from the Birmingham community.
Ashita Tolwani, a nephrologist at UAB, explains how COVID-19 is impacting patients and putting a strain on the availability of dialysis supplies.
The testing at UAB will investigate immune responses to the vaccine in mice — an important step before any Phase 1 human safety trial in patients later this year.

The study showed that 7.4 percent of veterans with a history of homelessness reported having an overdose in the past 3 years. Alcohol was the most commonly involved substance, but opioids and other drugs were common.

UAB researchers are now running tests and will soon have them available on a commercial platform, increasing output.
Page 19 of 37